MedTrace Logo

China Cimicifuga Trial of Climacteric Complaint Control

NCT00622986 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2008-02-25

No results posted yet for this study

Summary

This study is designed to determine whether an extract of Cimicifuga Foetida L. is safe and efficacious to relieve the climacteric symptoms of Chinese women

Conditions

  • Climacteric Symptoms

Interventions

DRUG

an extract of Cimicifuga Foetida L.

Each patient will be given the medication of extract of Cimicifuga Foetida L. 2 tablets each day for 3 months.

DRUG

an extract of Cimicifuga Foetida L.

Each patient will be given the medication of extract of Cimicifuga Foetida L. 2 tablets each day for 3 months.

DRUG

placebo

Each patient will be given placebo of 2 tablets each day for 3 months.

DRUG

placebo

Each patient will be given placebo of 2 tablets each day for 3 months.

Sponsors & Collaborators

  • Shandong Luye Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Shouqing Lin, MD · Beijing Union Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00622986 on ClinicalTrials.gov